These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 4689566)

  • 1. [Attempt to decrease the serum cholesterol level by oral administration of calcium].
    Kocián J; Vyskocilová L; Zádĕra L; Pechar J
    Cas Lek Cesk; 1973 Mar; 112(9):272-6. PubMed ID: 4689566
    [No Abstract]   [Full Text] [Related]  

  • 2. Long term human studies on the lipid effects of oral calcium.
    Bierenbaum ML; Fleischman AI; Raichelson RI
    Lipids; 1972 Mar; 7(3):202-6. PubMed ID: 5021330
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of oral calcium carbonate administration on serum lipoproteins of children with familial hypercholesterolaemia (type II-A).
    Groot PH; Grose WF; Dijkhuis-Stoffelsma R; Fernandes J; Ambagtsheer JJ
    Eur J Pediatr; 1980 Oct; 135(1):81-4. PubMed ID: 7449793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On the influence of oral calcium administration on total cholesterol and total lipids in human serum].
    Maibach E
    Wien Med Wochenschr; 1968 Dec; 118(49):1059-62. PubMed ID: 5717905
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term effects of pravastatin on serum lipid levels in elderly patients with hypercholesterolemia.
    Morimoto S; Koh E; Fukuo K; Higaki J; Ikegami H; Miki T; Hata T; Ogihara T
    Clin Ther; 1994; 16(5):793-803. PubMed ID: 7859238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral calcitriol pulse therapy on the lipid, calcium, and glucose homeostasis of hemodialysis-patients: its safety in a combination with oral calcium carbonate.
    Khajehdehi P; Taheri S
    J Ren Nutr; 2003 Apr; 13(2):78-83. PubMed ID: 12671829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a chronic therapy with the pineal hormone melatonin on cholesterol levels in idiopathic hypercholesterolemic patients.
    Pittalis S; Lissoni P; Giani L; Casati M; Kropacek N; Orfanò S; Giavolucci F; Merlini D
    Recenti Prog Med; 1997 Sep; 88(9):401-2. PubMed ID: 9323901
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcium carbonate treatment of uremic acidosis.
    Berlyne GM
    Isr J Med Sci; 1971 Nov; 7(11):1235-9. PubMed ID: 5159605
    [No Abstract]   [Full Text] [Related]  

  • 9. The requirement of low calcium dialysate in patients on continuous ambulatory peritoneal dialysis receiving calcium carbonate as a phosphate binder.
    Cheng IK; Lu HB; Chan CY; Cheng SW; Robinson JD; Tam SC; Lo WK; Cheung WC
    Clin Nephrol; 1993 Aug; 40(2):100-5. PubMed ID: 8222365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication for hypercholesterolemia and the risk of nonfatal acute myocardial infarction: case-control study in Japan.
    Circ J; 2002 May; 66(5):463-8. PubMed ID: 12030341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE-/-) mice with chronic renal failure.
    Phan O; Ivanovski O; Nikolov IG; Joki N; Maizel J; Louvet L; Chasseraud M; Nguyen-Khoa T; Lacour B; Drüeke TB; Massy ZA
    Nephrol Dial Transplant; 2008 Jan; 23(1):82-90. PubMed ID: 17977878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biphenabid (Probucol): a new hypocholesterolemic agent.
    Kalams Z; Dacquisto M; Kornett GS
    Curr Ther Res Clin Exp; 1971 Nov; 13(11):692-4. PubMed ID: 5000716
    [No Abstract]   [Full Text] [Related]  

  • 13. Calcium salts of keto-amino acids, a phosphate binder alternative for patients on CAPD.
    Macia M; Coronel F; Navarro JF; Gallego E; Herrero JA; Méndez ML; Chahin J; García J
    Clin Nephrol; 1997 Sep; 48(3):181-4. PubMed ID: 9342490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of gamma-ketophenylbutazone (Ketazon SPOFA) on the level of serum cholesterol].
    Sitar J
    Vnitr Lek; 1968 Mar; 14(3):228-34. PubMed ID: 5638959
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of protamine on cholesterol, triglycerides and blood serum proteins during the dynamics of experimental hypercholesterolemia].
    Bozhko GKh; Voloshin PV; Boĭko TP; Kostiukovskaia LS
    Vopr Med Khim; 1993; 39(3):8-12. PubMed ID: 8333197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buffering effects of calcium carbonate as clarified by sevelamer hydrochloride monotherapy.
    Akatsuka T; Mochizuki T; Koike T
    Ther Apher Dial; 2008 Jun; 12(3):216-25. PubMed ID: 18503699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iatrogenic hypercalcemia in hemodialysis patients in spite of the use of low dialysate calcium.
    Goicoechea M; Pascual N; Zaleski M; Andrea C; Hernández J; de Sequera P
    Clin Nephrol; 1997 Jul; 48(1):67-8. PubMed ID: 9247790
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of chronic administration of calcium carbonate on the bioavailability of oral ciprofloxacin.
    Sahai J; Healy DP; Stotka J; Polk RE
    Br J Clin Pharmacol; 1993 Mar; 35(3):302-4. PubMed ID: 8471407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [D-thyroxine in hypercholesterolemia--an attempt at critical evaluation].
    Wadman B; Werner I; Dano G; Levander-Lindgren M
    Nord Med; 1969 May; 81(22):691-7. PubMed ID: 4978739
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia.
    Ballantyne CM; Blazing MA; King TR; Brady WE; Palmisano J
    Am J Cardiol; 2004 Jun; 93(12):1487-94. PubMed ID: 15194018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.